Mesoblast Limited
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $2.4M | $42.5M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | — | — |
| Operating Income | $-90.2M | $-90.8M |
| Operating Margin | -3,740.3% | -213.5% |
| Interest Expense | — | — |
| Pretax Income | $-90.2M | $-90.8M |
| Income Tax Expense | $-13.4M | $-86.7M |
| Net Income | $-76.8M | $-4.1M |
| Net Margin | -3,184.7% | -9.7% |
| EPS (Basic) | $-0.19 | $-0.01 |
| EPS (Diluted) | $-0.19 | $-0.01 |
| Shares Outstanding (Basic) | — | — |
| Shares Outstanding (Diluted) | — | — |
| Dividends Per Share | — | — |